- Home
- Equipment
- usa district of columbia
- preclinical data from cytotil15 program
Intellia Preclinical Data From Cytotil15 Program Equipment & Supplies In In Usa District Of Columbia
1 equipment items found
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
The first patient was dosed with our investigational genome editing treatment for transthyretin (ATTR) amyloidosis in November 2020. Our modular approach enables us to optimize the power and versatility of the CRISPR/Cas9 technology and, importantly, allows us to rapidly develop therapeutics for numerous diseases that currently have limited treatment ...